Skip to main content
News
Events
Contact us
Close Search
search
Menu
About us
About us
Team
Work with us
Our offering
Our offering
FAQs
Portfolio
Success stories
Partners
Apply
Apply
FAQs
search
News
Filter
All
All
Features
Interviews
Portfolio news
Featured
Portfolio news
Salvina Therapeutics joins BaseLaunch portfolio
Featured
Portfolio news
TOLREMO therapeutics secures USD 39 million
Featured
Portfolio news
Alentis Therapeutics receives FDA Fast Track Designation for ALE.C04
Features
What you need to know about building your biotech startup
Features
BaseLaunch Summer Get-Together 2023
Featured
Portfolio news
Versameb strengthens its Board of Directors
Featured
Portfolio news
Cimeio Therapeutics and Prime Medicine announce research collaboration
Features
How Swiss life sciences startups can compete globally
Features
Bridge Biotherapeutics’ partnering strategy and growth by external innovation
Featured
Portfolio news
Phialogics AG appoints Prof. Dr. Erich Schlick as Chairman of its Board of Directors
Featured
Portfolio news
Phialogics closed a €600k pre-seed financing round with HTGF
Featured
Portfolio news
Engimmune Therapeutics appoints Dr. Lars Nieba as Chief Executive Officer
Portfolio news
BaseLaunch Portfolio has raised over half a billion dollars to date!
Portfolio news
Alentis Therapeutics closes $105M funding round Led by Jeito Capital, Novo Holdings and RA Capital Management
Portfolio news
FimmCyte joins BaseLaunch Portfolio
Features
What startups need to know about term sheets, legal due diligence and employee incentives
Features
Building biotech companies and raising venture capital financing
Features
Raising $50M series A with Cimeio Therapeutics
Featured
Portfolio news
NXI Therapeutics Expands Management Team and Board Ahead of Next Growth Stage
Features
Basel – A Major Powerhouse in Cancer Research
Interviews
Podcast: Never underestimate the true value of IP with Philipp Marchand
Portfolio news
Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022
All
BaseLaunch and WuXi Biologics announce their partnership
Features
Three Pillars for Setting up Biotech Startups for Success
Portfolio news
Phialogics joins BaseLaunch Portfolio
Features
Roivant’s growth story
All
BaseLaunch and Schrödinger announce their partnership
Features
BaseLaunch’s Mission: Building Exceptional Biotech Companies
All
Charles River announces partnership with BaseLaunch
Featured
Portfolio news
InCephalo AG Announces Appointment of Lauren E. Abrey, MD as Chief Medical Officer
Do you have a question? Get in touch
info@baselaunch.ch
Contact us
Close Menu
About us
About us
Team
Work with us
Our offering
Our offering
FAQs
Portfolio
Success stories
Partners
Apply
Apply
FAQs
News
Events
Contact us